Latest Insider Transactions at Oscar Health, Inc. (OSCR)
This section provides a real-time view of insider transactions for Oscar Health, Inc. (OSCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oscar Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oscar Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 08
2023
|
Jeffery H Boyd |
BUY
Grant, award, or other acquisition
|
Direct |
19,751
+15.76%
|
-
|
Jun 08
2023
|
David Plouffe |
BUY
Grant, award, or other acquisition
|
Direct |
19,751
+15.76%
|
-
|
Jun 08
2023
|
Elbert O. Robinson Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
19,751
+15.76%
|
-
|
Jun 06
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
11,859
-4.85%
|
$94,872
$8.39 P/Share
|
Jun 06
2023
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,955
-5.19%
|
$191,640
$8.39 P/Share
|
Jun 05
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+11.33%
|
-
|
Jun 05
2023
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+11.92%
|
-
|
Jun 02
2023
|
Sid Sankaran |
SELL
Open market or private sale
|
Direct |
137,826
-39.91%
|
$964,782
$7.15 P/Share
|
Jun 02
2023
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,267
-12.38%
|
$36,869
$7.15 P/Share
|
Jun 02
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
16,324
-7.11%
|
-
|
Jun 02
2023
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,597
-12.48%
|
$81,179
$7.15 P/Share
|
Jun 02
2023
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.55%
|
$102,781
$7.15 P/Share
|
Jun 01
2023
|
Sid Sankaran |
BUY
Exercise of conversion of derivative security
|
Direct |
227,848
+39.75%
|
-
|
Jun 01
2023
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,430
+13.01%
|
-
|
Jun 01
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,394
+8.24%
|
-
|
Jun 01
2023
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,872
+18.06%
|
-
|
Jun 01
2023
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,592
+5.07%
|
-
|
Mar 06
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
12,473
-6.21%
|
$49,892
$4.88 P/Share
|
Mar 06
2023
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,764
-7.69%
|
$123,056
$4.88 P/Share
|
Mar 05
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+13.47%
|
-
|
Mar 05
2023
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+13.51%
|
-
|
Mar 02
2023
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,480
-11.75%
|
$13,920
$4.75 P/Share
|
Mar 02
2023
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,252
-11.46%
|
$29,008
$4.75 P/Share
|
Mar 02
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
3,266
-1.89%
|
$13,064
$4.75 P/Share
|
Mar 02
2023
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,981
-1.16%
|
$15,924
$4.75 P/Share
|
Mar 02
2023
|
Sid Sankaran |
SELL
Open market or private sale
|
Direct |
110,396
-48.45%
|
$441,584
$4.75 P/Share
|
Mar 01
2023
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,932
+14.12%
|
-
|
Mar 01
2023
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,425
+24.4%
|
-
|
Mar 01
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+3.9%
|
-
|
Mar 01
2023
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+2.01%
|
-
|
Mar 01
2023
|
Sid Sankaran |
BUY
Exercise of conversion of derivative security
|
Direct |
227,848
+50.0%
|
-
|
Dec 07
2022
|
Laura W Lang |
BUY
Grant, award, or other acquisition
|
Direct |
31,506
+50.0%
|
-
|
Dec 07
2022
|
William Gassen |
BUY
Grant, award, or other acquisition
|
Direct |
31,506
+50.0%
|
-
|
Dec 06
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,397
-8.58%
|
$62,794
$2.64 P/Share
|
Dec 06
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
17,456
-9.53%
|
$34,912
$2.64 P/Share
|
Dec 05
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+14.58%
|
-
|
Dec 05
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+14.57%
|
-
|
Dec 02
2022
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
1,624
-5.65%
|
$3,248
$2.84 P/Share
|
Dec 02
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,369
-1.1%
|
$6,738
$2.84 P/Share
|
Dec 02
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
3,813
-2.45%
|
$7,626
$2.84 P/Share
|
Dec 02
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,281
-12.78%
|
$12,562
$2.84 P/Share
|
Dec 02
2022
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,789
-11.89%
|
$5,578
$2.84 P/Share
|
Dec 01
2022
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,170
+10.1%
|
-
|
Dec 01
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+2.23%
|
-
|
Dec 01
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+4.31%
|
-
|
Dec 01
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,425
+29.36%
|
-
|
Dec 01
2022
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,930
+17.55%
|
-
|
Oct 03
2022
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
11,729
-44.66%
|
$46,916
$4.96 P/Share
|
Sep 06
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
17,532
-10.54%
|
$87,660
$5.53 P/Share
|
Sep 06
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,615
-9.53%
|
$158,075
$5.53 P/Share
|